| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 143.240 | 122.921 | - | - | - | 112.541 | 99.607 | - | - | - |
| Total Income - EUR | 143.242 | 122.922 | - | - | - | 112.541 | 99.607 | - | - | - |
| Total Expenses - EUR | 139.174 | 118.758 | - | - | - | 111.646 | 97.881 | - | - | - |
| Gross Profit/Loss - EUR | 4.068 | 4.164 | - | - | - | 895 | 1.726 | - | - | - |
| Net Profit/Loss - EUR | 3.417 | 3.493 | - | - | - | 137 | 755 | - | - | - |
| Employees | 5 | 5 | - | - | - | 5 | 5 | - | - | - |
Check the financial reports for the company - Basarab Farmamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | - | - | 0 | 0 | - | - | - |
| Current Assets | 21.135 | 30.196 | - | - | - | 38.554 | 44.011 | - | - | - |
| Inventories | 14.257 | 25.865 | - | - | - | 32.299 | 36.221 | - | - | - |
| Receivables | 4.651 | 3.620 | - | - | - | 4.259 | 6.751 | - | - | - |
| Cash | 2.227 | 711 | - | - | - | 1.996 | 1.038 | - | - | - |
| Shareholders Funds | -37.504 | -33.629 | - | - | - | -23.044 | -21.778 | - | - | - |
| Social Capital | 45 | 45 | - | - | - | 41 | 40 | - | - | - |
| Debts | 59.165 | 64.344 | - | - | - | 62.125 | 66.435 | - | - | - |
| Income in Advance | 0 | 0 | - | - | - | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Basarab Farmamed S.r.l.